Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • SOP Guidelines
    • SOP Development
    • SOP Training
    • SOP Compliance Monitoring
    • SOP Revision Processes
    • Pharmaceutical SOP templates
    • GMP documentation SOP
    • Data integrity SOP pharma
    • Manufacturing SOP pharmaceutical
    • FDA SOP guidance
    • eQMS SOP workflows
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • GMP Audit Findings
    • Non-Compliance
      • SOP Absence
      • Revision Control
      • Non-Adherence
      • Poor Writing
      • Training Failure
      • Data Integrity Gaps
      • Mismatch Between SOPs and Practice
      • Critical Operations
      • Regulatory Change
      • Emergency Changes
      • Third-Party SOPs
      • Inspection Readiness
      • Deviation Handling
      • CAPA Integration
      • Validation Alignment
      • System Integration
      • Uncontrolled Distribution
      • SOP Implementation Gaps
      • SOP Alignment with Validation
      • Change Control Linkage
  • Toggle search form

Tag: QA oversight failure

Verbal Instructions Without SOP Addendum: Regulatory Risk in Critical Events

Posted on By

Verbal Instructions Without SOP Addendum: Regulatory Risk in Critical Events GMP Risks of Verbal Instructions Without SOP Addendum During Critical Events Introduction to the Audit Finding 1. Verbal Orders Bypass SOP Controls Issuing verbal instructions during critical operations without SOP addendums undermines written procedural control — a core GMP principle. 2. Common in Emergency or…

Read More “Verbal Instructions Without SOP Addendum: Regulatory Risk in Critical Events” »

Emergency Changes, GMP Audit Findings

SOPs Routinely Bypassed in Practice: GMP Non-Adherence Risks and Remedies

Posted on By

SOPs Routinely Bypassed in Practice: GMP Non-Adherence Risks and Remedies Operational SOP Bypass in Pharmaceutical Facilities: A Hidden GMP Threat Introduction to the Audit Finding 1. Informal Practices Operators often develop their own shortcuts, deviating from the approved SOPs. 2. Silent Deviation Culture When SOPs are ignored routinely, deviations become normalized and go undocumented. 3….

Read More “SOPs Routinely Bypassed in Practice: GMP Non-Adherence Risks and Remedies” »

GMP Audit Findings, Non-Adherence

Uncontrolled Revision of Documents Without QA Approval: A GMP Compliance Risk

Posted on By

Uncontrolled Revision of Documents Without QA Approval: A GMP Compliance Risk GMP Risk of Document Revisions Without QA Oversight and Approval Introduction to the Audit Finding 1. Undocumented Revisions When documents such as SOPs or protocols are revised without formal QA approval, changes go undocumented and unverified. 2. Bypassed Quality Gate QA serves as the…

Read More “Uncontrolled Revision of Documents Without QA Approval: A GMP Compliance Risk” »

GMP Audit Findings, Revision Control

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Gels V 2.0
  • Injectables V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme